To this end, we tested six strains with different characteristics with PD-1 antibody and CFA (Table 1) and successive experiments with anti-CTLA-4 with anti-PD-1, in the presence or absence of tumor antigen (Table 2). The gene discussed is CTLA4; the disease is neoplasm.